BIO.B Bio-Rad Laboratories-B
- 279.910
- 0.0000.00%
Bio-Rad Laboratories-B News
Bio-Rad Laboratories Names Roop Lakkaraju as New CFO
Top Gap Ups and Downs on Friday: BKNG, MELI, EOG and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Evelo Biosciences Enters Into Termination and Surrender Pact With Bio-Rad
Research Alert: CFRA Retains Buy Opinion On Shares Of Bio-rad Laboratories, Inc.
We cut our target by $149 to $450, 25.4x our 2024 EPS estimate, a discount to BIO's five-year historical forward P/E average. We trim our 2023 EPS estimate by $0.46 to $15.30 and keep 2024's at $17.71.
Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume Increase
Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Rating) saw unusually-high trading volume on Thursday . Approximately 200 shares traded hands during trading, an increase of 2,757% from the previous sessi
Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year High at $464.10
Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Rating)'s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $464.10 and last traded at $464.10, with a volume
Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits
SAN DIEGO and HERCULES, Calif., Feb. 8, 2023 /PRNewswire/ -- Element Biosciences, Inc. — the developer of an innovative DNA sequencing platform disrupting genomics — and Bio-Rad Laboratories, Inc. (NYSE:BIO), a global
Preview: Bio-Rad Laboratories\'s Earnings
Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here\'s what investors need to know before the announcement. Analysts estimate that Bio-R
Overview Of Value Stocks In The Healthcare Sector
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indi
Press Release: Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021
Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021 HERCULES, Calif.--(BUSINESS WIRE)--October 15, 2021-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global
Meet members of the 2021 IPO class: life sciences tools (part 2)
With a list of 62 recent IPOs making entry to the Russell 2000 small-cap index after index provider FTSE Russell implemented its Q3 recalibrations, we discuss the recently-IPOd healthcare stocks joini
IsoPlexis focused on accelerating drug development sets IPO terms valuing it up to $600M
On Friday, IsoPlexis (ISO), a life sciences company with a range of products designed to accelerate therapeutic development, filed the details of its upcoming IPO. The potential listing on Nasdaq und
5 Value Stocks To Watch In The Healthcare Sector
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as in
IPO Update: Seer Has $150 Million IPO In Its Sights
SummarySeer has filed to raise $150 million in an IPO of its Class A stock.The firm is preparing to commercialize its protein analysis system.SEER enjoys additional existing investor interest in the IPO, but I'm leery of the valuation; I can see 'risk-on' IPO investors being interested, but I'm cautious on SEER's IPO. Looking for more investing ideas like this one? Get them exclusively at IPO Edge. Get started today »
Analysis
Price Target
No Data
